Giuseppe Zagotto

Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2

Giorgio Cozza, Marco Mazzorana, E. Papinutto et al. · Biochemical Journal · 2009 · 158 citations · Full text

Medicinal Chemistry, Virtual Screening, Chemoprevention Strategy +14

Identification of Ellagic Acid as Potent Inhibitor of Protein Kinase CK2:  A Successful Example of a Virtual Screening Application

Giorgio Cozza, Paolo Bonvini, Elisa Zorzi et al. · Journal of Medicinal Chemistry · 2006 · 150 citations · Full text

A QSAR Model for in Silico Screening of MAO-A Inhibitors. Prediction, Synthesis, and Biological Assay of Novel Coumarins

Lourdes Santana, Eugenio Uriarte, Humberto González‐Díaz et al. · Journal of Medicinal Chemistry · 2005 · 135 citations · Full text

Drug Target, Organic Chemistry, Pharmacotherapy +17

Coumarin as Attractive Casein Kinase 2 (CK2) Inhibitor Scaffold: An Integrate Approach To Elucidate the Putative Binding Motif and Explain Structure–Activity Relationships

Adriana Chilin, Roberto Battistutta, Andrea Bortolato et al. · Journal of Medicinal Chemistry · 2008 · 132 citations

Tetrabromocinnamic Acid (TBCA) and Related Compounds Represent a New Class of Specific Protein Kinase CK2 Inhibitors

Mario A. Pagano, Giorgia Poletto, Giovanni Di Maira et al. · ChemBioChem · 2006 · 126 citations

Bioorganic Chemistry, Chemoprevention Strategy, Protein Kinase Ck2 +21